If approved, the new drug would be sold through the sales channels ... a gene therapy approach for HAE with Orchard Therapeutics. Leniolisib is next in line to tap into Pharming's rare disease ...
Leniolisib has been being given a speedy ... effects limiting patients' physical activity or wellbeing. If approved, the new drug would be sold through commercial channels set up by Pharming ...
Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback